Status:
COMPLETED
A Comparison of Protein-bound and Large Molecular Weight Uremic Toxin Removals With Novel Super High-flux Dialyzer Between Hemodialysis and High Volume Online HDF Modalities
Lead Sponsor:
Chulalongkorn University
Conditions:
Uremic; Toxemia
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The goal of this prospective, randomized, crossover study is to study about using super high-flux dialyzer in the chronic hemodialysis patients. The main questions aim to answer are the reduction rat...
Detailed Description
Other secondary outcomes that the researcher wants to study are 1. The reduction ratio of Beta2microglobulin, kappa and lambda free light chain 2. Serum albumin and dialysate albumin loss 3. Quality ...
Eligibility Criteria
Inclusion
- Chronic hemodialysis patients in King Chulalongkorn Memorial hospital
- Residual renal function less than 100 ml/day
Exclusion
- Dialyzer allergy
- Malnutrition requiring intradialytic parenteral nutrition
- Cirrhosis child C or decompensated cirrhosis
- Active uncontrolled infection
- Active cardiovascular disease
- Advanced stage malignancy
- Predicted to be undergone living related kidney transplant within 1 year
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06567483
Start Date
May 1 2023
End Date
March 1 2024
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Chulalongkorn university
Pathum Wan, Bangkok, Thailand, 10330